BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Amorfix Life Sciences Ltd. 

3403 American Drive

Mississauga  Ontario  L4V 1T4  Canada
Phone: 416-4847-6898 Fax: 416-847-6899


SEARCH JOBS




Industry
Biotechnology

Segment
Life Sciences





 Company News
Amorfix Life Sciences Ltd. Presents Scientific Update For Its Alzheimer’s Disease Diagnostic At Alzheimer’s Disease Conference 7/17/2014 8:53:31 AM
Amorfix Life Sciences Ltd. Awarded Broad United States Patent For Misfolded SOD1-Targeted Treatment Of ALS 7/17/2014 8:46:11 AM
Amorfix Life Sciences Ltd. Reports Update on Lead Ovarian Cancer Program 8/14/2013 10:12:33 AM
Amorfix Life Sciences Ltd. Announces Fiscal 2014 First Quarter Results 8/13/2013 6:27:38 AM
Amorfix Life Sciences Ltd. to Provide ALS Diagnostic Update at the MND/ALS 24th International Symposium 7/17/2013 6:11:27 AM
Amorfix Life Sciences Ltd. Announces Fiscal 2013 Year End Results 7/1/2013 6:35:30 AM
Amorfix Life Sciences Ltd. Provides Update on Ovarian Cancer Preclinical Studies 6/5/2013 11:02:23 AM
Amorfix Life Sciences Ltd. Announces Breakthrough Scientific Discovery and Provides Update for Its Ovarian Cancer Therapeutic Antibody Program 4/9/2013 10:39:00 AM
Amorfix Life Sciences Ltd. Acquires SOD1 Technology and Provides Update on Financing 3/12/2012 9:49:09 AM
Amorfix Life Sciences Ltd. Licenses ALS Antibodies To Biogen Idec, Inc. (Massachusetts) (BIIB); Amorfix To Receive $1 Million Upfront 7/15/2010 7:37:21 AM
1234